retatrutide expanded access program Retatrutide: A deep dive Part 1 in a series covering what is and does as well as it's current status with the FDA Reports by STAT News claim

doi: 10.1111/dom.14089 231 SamsonSLGarberA

"When you stop these low doses of these drugs, we don't know what's going to happen." On average, people will lose significantly less weight than they would with the maximum dose of a brand name version of the drug, McGowan agrees

This is great for weight loss because it keeps food in your stomach longer, making you feel more satiated

Zepbound mimics two, adding GIP

CBO notes that some analyses of weight loss via GLP-1s found they reduced all-cause mortality in certain patients, while other methods had mixed results notably bariatric surgery, which did not clearly lower future health spending and was heavily dependent on individual adherence to post-surgery lifestyle changes

In September 2023, the FDA did update the semaglutide label to add ileus (a severe intestinal blockage) as a warning, demonstrating that the agency does act on emerging safety signals when the evidence supports it